SCHEMBL1289727

SCHEMBL1289727

CC(NC(=O)C1CC1CN1C(=O)c2ccccc2C1=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.51
KCNQ3 O43525 2/20 0.51
KCNQ2 O43526 2/20 0.51
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50
KMT2A Q03164 1/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
KCNQ4 P56696 1/20 0.44
KCNQ5 Q9NR82 1/20 0.44
FBP1 P09467 1/20 0.44
DRD2 P14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20168263 0.80 RECQL (0.60) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL20168265 0.80 RECQL (0.60) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL20168550 0.80 RECQL (0.60) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL20168552 0.80 RECQL (0.60) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL24895182 0.77 HPGD (0.42) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL23423323 0.77 HPGD (0.42) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL23423077 0.77 HPGD (0.42) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL23423078 0.77 HPGD (0.42) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL29736139 0.77 HPGD (0.42) RECQLKCNQ3KCNQ2USP2ALOX15
SCHEMBL27748279 0.77 RECQL (0.56) RECQLKCNQ3KCNQ2USP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012046247-A2 PROCESS FOR THE PREPARATION OF (±M1R(S), 2SRR)L-2-(AMINOMETHYL)-N,N-DIETHYL-L-PHENYLCYCLOPROPANE CARBOXAMIDE HYDROCHLORIDE MSN LABORATORIES LIMITED (IN) 2012-04-12 WO claimed
US-20100274050-A1 SOLID MILNACIPRAN AND PROCESS FOR THE PREPARATION OF THE SAME GLENMARK GENERICS LIMITED (IN) 2010-10-28 US claimed
WO-2012046247-A2 PROCESS FOR THE PREPARATION OF (±M1R(S), 2SRR)L-2-(AMINOMETHYL)-N,N-DIETHYL-L-PHENYLCYCLOPROPANE CARBOXAMIDE HYDROCHLORIDE MSN LABORATORIES LIMITED (IN) 2012-04-12 WO disclosed
US-20100274050-A1 SOLID MILNACIPRAN AND PROCESS FOR THE PREPARATION OF THE SAME GLENMARK GENERICS LIMITED (IN) 2010-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100274050-A1 SOLID MILNACIPRAN AND PROCESS FOR THE PREPARATION OF THE SAME GCG, AREG, CTSG RECQL 2799/4885KCNQ3 2573/4885KCNQ2 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.